- Home
- WDAY vs IQV Comparison
WDAY vs IQV Comparison
Compare WDAY & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WDAY | IQV |
|---|---|---|
| Founded | 2005 | 1982 |
| Country | United States | United States |
| Employees | N/A | 93000 |
| Industry | EDP Services | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.1B | 35.1B |
| IPO Year | 2012 | 2013 |
Fundamental Metrics
Financial Performance| Metric | WDAY | IQV |
|---|---|---|
| Price | $200.36 | $259.99 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 34 | 16 |
| Target Price | $202.50 | ★ $227.13 |
| AVG Volume (30 Days) | ★ 5.0M | 1.4M |
| Earning Date | 05-21-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 32.82 | 4.67 |
| EPS | 0.87 | ★ 1.61 |
| Revenue | $2,143,050,000.00 | ★ $9,739,000,000.00 |
| Revenue This Year | $13.80 | $6.77 |
| Revenue Next Year | $11.30 | $5.89 |
| P/E Ratio | $226.78 | ★ $159.10 |
| Revenue Growth | 36.55 | ★ 41.60 |
| 52 Week Low | $110.36 | $154.50 |
| 52 Week High | $249.85 | $260.30 |
Technical Indicators
Market Signals| Indicator | WDAY | IQV |
|---|---|---|
| Relative Strength Index (RSI) | 66.61 | 72.36 |
| Support Level | $114.67 | $218.57 |
| Resistance Level | $229.41 | N/A |
| Average True Range (ATR) | 10.96 | 7.66 |
| MACD | 1.01 | 0.61 |
| Stochastic Oscillator | 57.22 | 96.77 |
Price Performance
Historical ComparisonAbout WDAY Workday Inc.
Workday is a software company that offers human capital management, financial management, and business planning solutions for enterprises. Known for being a cloud-only software provider, Workday was founded in 2005 and is headquartered in Pleasanton, California.
About IQV IQVIA Holdings Inc.
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.